Company Filing History:
Years Active: 2013-2015
Title: Chih-Hsiung Wu: Innovator in Breast Cancer Research
Introduction
Chih-Hsiung Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of breast cancer research, particularly in understanding the mechanisms of nicotine-derived compounds and their effects on cancer cells. With a total of 2 patents, his work is paving the way for innovative treatments and preventive measures against breast cancer.
Latest Patents
Wu's latest patents include a method for identifying candidate compounds that may inhibit α9-nAChR overexpression or estrogen receptor-dependent transcription in nicotine-derived-compound-induced breast cancer cells. This invention focuses on the role of the α9-nAChR promoter and its interaction with estrogen receptors, highlighting the importance of this pathway in cancer progression. Another significant patent involves the development of small interfering RNAs (siRNAs) aimed at inhibiting the expression of α9-nAChR, which is associated with tumorigenesis in breast cancer. This invention provides methods for the prevention, inhibition, and treatment of malignant progression in breast cancer, showcasing Wu's commitment to advancing cancer research.
Career Highlights
Chih-Hsiung Wu is affiliated with Taipei Medical University, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on breast cancer treatment and prevention strategies. Wu's innovative approaches are contributing to a deeper understanding of cancer biology and therapeutic interventions.
Collaborations
Wu collaborates with esteemed colleagues, including Chia-Hwa Lee and Ching-Shyang Chen. Their combined expertise enhances the research efforts and fosters a collaborative environment for innovation in cancer research.
Conclusion
Chih-Hsiung Wu is a dedicated inventor whose work in breast cancer research is making a significant impact. His innovative patents and collaborations are paving the way for new therapeutic strategies, ultimately contributing to the fight against cancer.